Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
07/27/1989 | WO1989006646A1 2-amino acetamide derivatives |
07/27/1989 | WO1989006547A1 A process for pasteurization of aqueous solutions of factor viii |
07/27/1989 | WO1989006546A1 Conjugation of polymer to colony stimulating factor-1 |
07/27/1989 | WO1989006545A1 Histamine release inhibitory factor and preparations therefore |
07/27/1989 | WO1989006544A1 Heteroligating antibodies and therapeutic uses thereof |
07/27/1989 | WO1989006541A1 Dna sequences, recombinant dna molecules and processes for producing stromal derived lymphopoietic factor-1 polypeptides |
07/27/1989 | WO1989006540A1 Diabetic control by combined insulin forms |
07/27/1989 | WO1989006536A1 Growth inhibiting agent and the use thereof |
07/27/1989 | WO1989006496A1 Increasing efficiency of animal performance |
07/27/1989 | WO1989006276A3 Hiv-2-type retroviruses of primates, vaccines, diagnostic and pharmaceutical compositions |
07/27/1989 | WO1989005650A3 Chemical process |
07/27/1989 | DE3902157A1 Amphiregulin, verfahren zu dessen herstellung und pharmazeutische mittel Amphiregulin, process for its preparation and pharmaceutical compositions |
07/27/1989 | DE3900626A1 Hirudin derivative |
07/27/1989 | DE3843054A1 Neue kristallform von cyclosporin, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese kristallform sowie ihre anwendung New crystal form of cyclosporin, processes for their preparation, pharmaceutical compositions containing said crystalline form as well as their use |
07/26/1989 | EP0325474A2 Receptor protein for human B cell stimulating factor-2 |
07/26/1989 | EP0325471A1 Method for suppressing the growth of normal and cancer cells |
07/26/1989 | EP0325400A1 Novel hybrid bacillus thuringiensis gene, plasmid, and transformed pseudomonas fluorescens |
07/26/1989 | EP0325262A2 Cloned genes encoding IG-CD4 fusion proteins and the use thereof |
07/26/1989 | EP0325225A2 Concentrates of coagulation factors II, VII, IX and/or X, their preparation and use, and method for the determination of coagulation factor VII |
07/26/1989 | EP0325224A2 Methods of producing secreted receptor analogs and biologically active peptide dimers. |
07/26/1989 | EP0325199A2 Fumagillin as angiostatic agent |
07/26/1989 | EP0325191A2 Composition and method for protecting against diseases caused by microorganisms |
07/26/1989 | EP0325160A2 Amino-acid glycerides, process for their preparation, medicaments containing them and their use |
07/26/1989 | EP0325044A2 Pharmacologically active cyclic peptide |
07/26/1989 | EP0325037A1 Bacterial strains |
07/26/1989 | EP0324867A1 Fc-binding protein and strain of producing the same |
07/26/1989 | EP0324811A1 Gas inlet for a plurality of various reaction gases in reaction vessels |
07/26/1989 | CN1034208A Process for the prepn. of peptide structures and immunogens containing them useful in the control of fertility |
07/25/1989 | US4851528 Anthraquinone derivatives |
07/25/1989 | US4851517 Tissue plasminogen activator oligosaccharide from normal human colon cells |
07/25/1989 | US4851509 Immunostimulant oligopeptides |
07/25/1989 | US4851388 Heptanoyl-glu-asp-ala-amino acid immunostimulants |
07/25/1989 | US4851387 5-substituted amino-4-hydroxy-pentanoic acid derivatives and their use |
07/25/1989 | US4851386 Method of treating precocious puberty |
07/25/1989 | US4851385 Luteinizing hormone releasing hormone |
07/25/1989 | US4851349 Expression vectors encoding cardionatrin and cardiodilatin |
07/25/1989 | US4851345 Absorption during fibrin chromatography, then non-absorption in lysine chromatography |
07/25/1989 | US4851334 Monoclonal antibodies specific to in vivo fragments derived from human fibrinogen, human fibrin I or human fibrin II |
07/25/1989 | US4851330 Method for detection, identification and quantitation of non-viral organisms |
07/25/1989 | US4851219 Method for the treatment of chronic myelogenous leukemia |
07/25/1989 | US4851211 LHRH analog formulations |
07/25/1989 | CA1257950A1 Therapeutic lhrh analogs |
07/19/1989 | EP0324712A2 Hirudin derivative |
07/19/1989 | EP0324597A2 Fibrin selective two-chain plasminogen activator |
07/19/1989 | EP0324574A2 Immunomodulating bryostatins |
07/19/1989 | EP0324556A2 Method to improve mRNA translation and use thereof for production of platelet factor-4 |
07/19/1989 | EP0324464A2 Use of TNF and LT for preparation of medicaments |
07/19/1989 | EP0324447A2 Means and process for producing a recombinant human interleukin-1 alpha polypeptide |
07/19/1989 | EP0324270A1 Biologically active peptides |
07/19/1989 | EP0324227A1 A composition of matter for increasing intracellular atp levels and physical performance levels and for increasing the rate of wound repair |
07/19/1989 | EP0324130A2 8-Glycine, 16-X, Des-19-Leucine-Calcitonin |
07/19/1989 | EP0324124A1 The cloning and sequencing of the gene which codes for a new pilinic subunit of Bordetella pertussis |
07/19/1989 | EP0125299B1 Glycosylated insulin derivatives |
07/18/1989 | USRE32992 Peptide process for preparation thereof and use thereof |
07/18/1989 | US4849525 Phosphinylcycloalkylcarbonyl and phosphinylcycloalkenylcarbonyl dipeptides |
07/18/1989 | US4849508 Pasteurization of immunoglobulin solutions |
07/18/1989 | US4849507 Diagnosis |
07/18/1989 | US4849506 Leukoregulin, an antitumor lymphokine, and its therapeutic uses |
07/18/1989 | US4849412 Methods and compositions for treating viral infections |
07/18/1989 | US4849408 Method of treatment of cerebral disturbances with oligopeptides containing tryptophan |
07/18/1989 | US4849407 Biologically active mosaic proteins |
07/18/1989 | US4849406 Aprotinin |
07/18/1989 | US4849405 Coacervate |
07/18/1989 | US4849404 Modified immunoglobulins |
07/18/1989 | US4849402 Therapeutic treatment of abnormal cell growth with follicle regulatory protein |
07/18/1989 | US4849352 Antibody purification process |
07/18/1989 | US4849349 Genes for biologically active proteins |
07/18/1989 | US4849329 Process for preparing lymphokine activated killer cells |
07/18/1989 | US4849218 Oral garlic preparations and process for preparing same |
07/18/1989 | CA1257750A1 Fish growth hormone |
07/18/1989 | CA1257749A1 Carboxyalkyl dipeptides for treating hypertension |
07/18/1989 | CA1257748A1 N-acyl derivatives of peptides, their preparation and their use in the treatment of disorders, and agents for this purpose |
07/18/1989 | CA1257747A1 Formyl-methionyl chemotatic peptide antibiotic conjugates useful in treating infections |
07/18/1989 | CA1257746A1 Homocyclic derivatives |
07/18/1989 | CA1257540A1 Peptide antibodies and their use in detecting oncogene products |
07/13/1989 | WO1989006283A1 Novel plasmid vector with pectate lyase signal sequence |
07/13/1989 | WO1989006281A1 Tris-kringle plasminogen activator with novel k2 insert |
07/13/1989 | WO1989006276A2 Hiv-2-type retroviruses of primates, vaccines, diagnostic and pharmaceutical compositions |
07/13/1989 | WO1989006241A1 Sorbin and peptide derivatives which increase aborption by the mucous membranes |
07/13/1989 | WO1989006240A1 Peptide corresponding to hiv-env 583-599, and analogs thereof and applications of the peptides |
07/13/1989 | WO1989006239A1 Elastase inhibiting polypeptides and process for their preparation by genetic recombination |
07/13/1989 | WO1989006139A1 Reduction of side effects of cancer therapy |
07/13/1989 | WO1989006138A1 UNIQUE ANTIGENIC EPITOPES ON IgE-BEARING B LYMPHOCYTES |
07/13/1989 | WO1989006137A1 Oral bilirubin therapy |
07/13/1989 | WO1989006136A1 Agent for prophylaxis and treatment of pancreatic disease or the like |
07/13/1989 | WO1989006135A1 Treatment of type 2 diabetes mellitus |
07/13/1989 | WO1989006134A1 Pharmaceutical preparation for treating immunodeficiency conditions |
07/12/1989 | EP0323805A2 Novel antibodies |
07/12/1989 | EP0323802A2 Monoclonal antibodies against, and cell surface antigen of, lung carcinoma |
07/12/1989 | EP0323769A1 Peptide structures, immunogens containing them, and their use in the control of fertility |
07/12/1989 | EP0323740A2 Linear analogs of atrial natriuretic peptides |
07/12/1989 | EP0323462A1 Use of interleukin-1 to induce development of multipotent hemopoietic cell populations. |
07/12/1989 | CN1033838A Ribozymes |
07/11/1989 | US4847363 Electrophoresis |
07/11/1989 | US4847362 Method for purifying antihemophilic factor |
07/11/1989 | US4847325 Conjugation of polymer to colony stimulating factor-1 |
07/11/1989 | US4847241 Fluorenyl substituted tyrosyl dipeptide amides which are useful in treating pain |
07/11/1989 | US4847201 DNA encoding for CSF-1 and accompanying recombinant systems |
07/11/1989 | US4847200 Enzyme cyclization of dipeptides |
07/11/1989 | US4847084 Ointment for the treatment of decubiti ulcers |